The Hindu·3 min read·medium
Novo Nordisk launches weekly insulin shot Awiqli in India
R
Reuters
✦AI Summary
Novo Nordisk has launched Awiqli, a once-weekly basal insulin injection, in India to treat type 1 and type 2 diabetes. The drug aims to improve patient compliance by reducing the frequency of injections from daily to weekly.
Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in India on Thursday (July 9, 2026), aiming to compete with daily-dose options on the market.
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in